Small supernumerary marker chromosomes (sSMC) are small additional chromosomes characterizable for their origin only by molecular cytogenetic approaches. sSMC have been reported previously in four types of syndromes associated with chromosomal imbalances: in ∼150 cases with Turner syndrome, 26 cases with Down syndrome and only one case each with Klinefelter syndrome and “Triple-X”-syndrome. Here we report the second case with an sSMC detected in addition to a Klinefelter karyotype. Molecular cytogenetics applying centromere-specific multicolor FISH (cenM-FISH) and a specific subcentromere-specific (subcenM-FISH) probe set characterized the sSMC as a dic(9)(:p12→q11.1::q11.1→ p11.1:). The reported patient was described with hypogonadism, gynaecomastia plus a bronchial carcinoma. The patient’s clinical features are discussed in connection with other Klinefelter cases and possible consequences of presence of the sSMC(9). Furthermore, a suggestion is made for the mode of sSMC-formation in this case.    

1.
Anderlid BM, Sahlen S, Schoumans J, Holmberg E, Ahsgren I, Mortier G, Speleman F, Blennow E: Detailed characterization of 12 supernumerary ring chromosomes using micro-FISH and search for uniparental disomy. Am J Med Genet 99:223–233 (2001).
2.
Bartels I, Schlueter G, Liehr T, von Eggeling F, Starke H, Glaubitz R, Burfeind P: Supernumerary small marker chromosome (SMC) and uniparental disomy 22 in a child with confined placental mosaicism of trisomy 22: trisomy rescue due to marker chromosome formation. Cytogenet Genome Res 101:103–105 (2003).
3.
Dewald GW: Isodicentric X chromosomes in humans: origin, segregation behaviour, and replication band patterns, in Sandberg AA (ed): Cytogenetics of the Mammalian X Chromosome, Part A, pp 405–426 (Allen R. Liss, New York 1983).
4.
Fernandez J, Pereira S, Campos A, Gosalvez J, Goyanes V: An extra band within the human 9qh+ region that behaves like the surrounding constitutive heterochromatin. J Med Genet 31:632–634 (1994).
5.
Harvey J, Jacobs PA, Hassold T, Pettay D: The parental origin of 47,XXY males. Birth Defects Orig Artic Ser 26:289–296 (1990).
6.
Liehr T, Claussen U, Starke H: Small supernumerary marker chromosomes (sSMC) in humans. Cytogenet Genome Res 107:55–67 (2004a).
7.
Liehr T, Mrasek K, Weise A, Kuechler A, von Eggeling F, Claussen U, Starke H: Characterization of small supernumerary marker chromosomes (sSMC) in human. Curr Genomics 5:279–286 (2004b).
8.
Lorda-Sanchez I, Petersen MB, Binkert F, Maechler M, Schmid W, Adelsberger P, Antonarakis SE, Schinzel A: A 48,XXY,+21 Down syndrome patient with additional paternal X and maternal 21. Hum Genet 87:54–56 (1991).
9.
Manea SR, Gershin IF, Babu A, Willner JP, Desnick R, Cotter PD: Mosaicism for a small supernumerary ring X chromosome in a dysmorphic, growth-retarded male: mos47,XXY/48,XXY,+r(X). Clin Genet 52:432–435 (1997).
10.
Nietzel A, Rocchi M, Starke H, Heller A, Fiedler W, Wlodarska I, Loncarevic IF, Beensen V, Claussen U, Liehr T: A new multicolor-FISH approach for the characterization of marker chromosomes: centromere-specific multicolor-FISH (cenM-FISH). Hum Genet 108:199–204 (2001).
11.
Starke H, Seidel J, Henn W, et al: Homologous sequences at human chromosome 9 bands p12 and q13→q21.1 are involved in different patterns of pericentric rearrangements. Eur J Hum Genet 10:790–800 (2002).
12.
Starke H, Nietzel A, Weise A, et al: Small supernumerary marker chromosomes (SMCs): genotype-phenotype correlation and classification. Hum Genet 114:51–67 (2003).
13.
Stefanou EG, Crocker M: A chromosome 21-derived minute marker in a mosaic trisomy 21 background: implications for risk assessments in marker chromosome cases. Am J Med Genet 127A:191–193 (2004).
14.
Verma RS, Babu A: Human Chromosomes – Manual of Basic Technologies, pp 6–71, 4th edition (Pergamon Press, New York 1998).
15.
Verma RS, Luke S, Brennan JP, Mathews T, Conte RA, Macera MJ: Molecular topography of the secondary constriction region (qh) of human chromosome 9 with an unusual euchromatic band. Am J Hum Genet 52:981–986 (1993).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.